6th Annual Drug Development Congress
02 Jun 2014 - 03 Jun 2014 - Geneva, Switzerland
The 6th Annual Drug Development congress offers an executive platform for networking and discussion. Delegates will benefit from the opportunity to:
Hear from and meet with the key innovators in predictive science and translational medicine. Previous attendees include: Executive Director, Safety Assessment, Novartis; Vice President, Translational Patient Safety, AstraZeneca; Head Clinical Pharmacokinetics, Bayer HealthCare
Discover collaborative solutions to drug development challenges. This summit brings together a host of experts to compare methods for maximising the role of PKPD in early decision-making, implementing exploratory toxicology throughout the pipeline and applying predictive science to multi-target therapies.
Discuss the latest innovations in drug development, including stem cell technology for predictive modelling, resistance biomarker studies and toxicogenomic applications for translational science.
Enjoy unparalleled networking opportunities. The two-day congress format combines dedicated networking breaks, pre-organised 1-2-1 meetings and our popular drinks reception. The exhibition hall and poster presentation spaces offer a relaxed and professional environment for discussion.
The Congress is co-located with the 15th Annual Drug Discovery Summit, a senior level event looking into medicinal chemistry, research strategy, discovery technology and drug design.
Contact Danielle Dalby to download the agenda and for attendance information on firstname.lastname@example.org or call +44 (0)1865 248455